| Patent | Date |
|---|
Use Of Sublingual Dexmedetomidine For The Treatment Of Agitation
App 20220031663 - NANDABALAN; Krishnan ; et al. | 2022-02-03 |
Predictive And Diagnostic Methods For Prostate Cancer
App 20210355541 - NANDABALAN; Krishnan ; et al. | 2021-11-18 |
Methods And Compositions For Treating Cancer By Modifying Multiple Arms Of The Immune System
App 20200317784 - NANDABALAN; Krishnan ; et al. | 2020-10-08 |
Use of ubiquitin-proteasome system inhibitors for treatment of tumors associated with neurofibromatosis type-2
Grant 10,610,563 - Nandabalan , et al. | 2020-04-07 |
Methods for reformulating and repositioning pharmaceutical data and devices thereof
Grant 10,572,631 - Nandabalan , et al. Feb | 2020-02-25 |
Use Of Sublingual Dexmedetomidine For The Treatment Of Agitation
App 20190365715 - NANDABALAN; Krishnan ; et al. | 2019-12-05 |
Use Of Src Family Kinase Inhibitor In Ribosomal Disorder
App 20190298720 - NANDABALAN; Krishnan | 2019-10-03 |
Immunomodulation Therapies For Cancer
App 20190008918 - UPMANYU; Sanatan ; et al. | 2019-01-10 |
Methods For Assessing Pharmaceutical Performance Across Therapeutic Areas And Devices Thereof
App 20180226156 - NANDABALAN; Krishnan ; et al. | 2018-08-09 |
Novel Immunomodulatory Therapeutic Strategies Targeting Tumors In Cancer
App 20180134771 - NANDABALAN; Krishnan ; et al. | 2018-05-17 |
Compositions And Methods For Preventing Tumor Growth And Treating Cancer By Targeting Lectin Galactoside-binding Soluble 3 Binding Protein
App 20180094058 - SHARMA; Himani ; et al. | 2018-04-05 |
Use Of Ubiquitin-proteasome System Inhibitors For Treatment Of Tumors Associated With Neurofibromatosis Type-2
App 20170360872 - NANDABALAN; Krishnan ; et al. | 2017-12-21 |
Prevention Or Treatment Of Sleep Disorders Using Dexmedetomidine Formulation
App 20170239221 - NEGI; Harsh ; et al. | 2017-08-24 |
Methods For Reformulating And Repositioning Pharmaceutical Data And Devices Thereof
App 20170220767 - NANDABALAN; Krishnan ; et al. | 2017-08-03 |
Systems And Methods To Classify And Rank Health Information
App 20160063202 - NANDABALAN; Krishnan | 2016-03-03 |
Haplotypes of the FCER1A gene
App 20050196829 - Chew, Anne ; et al. | 2005-09-08 |
Haplotypes of the UCP2 gene
App 20030207284 - Chew, Anne ; et al. | 2003-11-06 |
53BP2 complexes
Grant 6,627,405 - Nandabalan , et al. September 30, 2 | 2003-09-30 |
Haplotypes of the TNFRSF11B gene
App 20030175710 - Chew, Anne ; et al. | 2003-09-18 |
Haplotypes of the TNFRSF1A gene
App 20030165844 - Anastasio, Alison E. ; et al. | 2003-09-04 |
Identification and comparison of protein-protein interactions that occur in populations and identification of inhibitors of these interactors
App 20030119002 - Nandabalan, Krishnan ; et al. | 2003-06-26 |
Association of beta2-adrenergic receptor haplotypes with drug response
App 20030091998 - Drysdale, Connie M. ; et al. | 2003-05-15 |
Nlk1 protein and Nlk1 protein complexes
App 20030087412 - Nandabalan, Krishnan ; et al. | 2003-05-08 |
Haplotypes of the icam2 gene
App 20030082555 - Chew, Anne ; et al. | 2003-05-01 |
Drug target isogenes: polymorphisms in the Interleukin 4 Receptor Alpha gene
App 20030078220 - Chew, Anne ; et al. | 2003-04-24 |
Association of beta2-adrenergic receptor haplotypes with drug response
App 20030039979 - Liggett, Stephen B. ; et al. | 2003-02-27 |
p27 (Kip1) -FKBP-12 protein complexes
App 20030023034 - Nandabalan, Krishnan ; et al. | 2003-01-30 |
MDM interacting protein and methods of use thereof
App 20020098580 - Nandabalan, Krishnan ; et al. | 2002-07-25 |
Identification and comparison of protein--protein interactions that occur in populations and identification of inhibitors of these interactors
Grant 6,410,239 - Nandabalan , et al. June 25, 2 | 2002-06-25 |
Association of beta2-adrenergic receptor haplotypes with drug response
App 20010051712 - Drysdale, Connie M. ; et al. | 2001-12-13 |
Identification and comparison of protein-protein interactions that occur in populations
Grant 6,083,693 - Nandabalan , et al. July 4, 2 | 2000-07-04 |
Identification and comparison of protein-protein interactions that occur in populations and identification of inhibitors of these interactors
Grant 6,057,101 - Nandabalan , et al. May 2, 2 | 2000-05-02 |
CDK2 interactions
Grant 5,986,055 - Yang , et al. November 16, 1 | 1999-11-16 |
53BP2 complexes
Grant 5,977,311 - Nandabalan , et al. November 2, 1 | 1999-11-02 |
| 